
Advanced Proteome Therapeutics Corporation. Stock Analysis APC.H.V
Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of a new technology platform that is intended for the chemical modification of protein therapeutics. The company is headquartered in Burnaby, British Columbia. The firm is not engaged in any business operation and does not have any revenues.
Read More Advanced Proteome Therapeutics Corporation (APC.H.V) Chart
Key Statistics of Advanced Proteome Therapeutics Corporation (APC.H.V)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.01Volume
69.60KP/E Ratio (TTM)
0.2752 Week Range
Market Cap
210.00KAvg. Volume
77.80KDividend Yield
-Financial Metrics & Statements of Advanced Proteome Therapeutics Corporation (APC.H.V)
FAQ's for Advanced Proteome Therapeutics Corporation (APC.H.V)
- According to Musaffa’s Shariah screening methodology, Advanced Proteome Therapeutics Corporation (APC.H.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.